{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:25:16Z","timestamp":1781213116129,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00198-025-07824-3","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T02:58:34Z","timestamp":1766631514000},"page":"447-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radiofrequency Echographic Multi Spectrometry (REMS) for the evaluation of bone health in systemic lupus erythematosus (SLE)"],"prefix":"10.1007","volume":"37","author":[{"given":"Mariana Diz","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Orsolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isotta","family":"Galvagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Rotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Dartizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Benini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Fassio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-0755","authenticated-orcid":false,"given":"Giovanni","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"7824_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00223-017-0322-z","volume":"102","author":"IEM Bultink","year":"2018","unstructured":"Bultink IEM (2018) Bone disease in connective tissue disease\/systemic lupus erythematosus. Calcif Tissue Int 102:575\u2013591","journal-title":"Calcif Tissue Int"},{"key":"7824_CR2","first-page":"2535","volume":"28","author":"AM Huisman","year":"2001","unstructured":"Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW, Bijlsma JW, Bell DA (2001) Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 28:2535\u20132539","journal-title":"J Rheumatol"},{"key":"7824_CR3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1177\/0961203313498802","volume":"22","author":"XL Tang","year":"2013","unstructured":"Tang XL, Griffith JF, Qin L, Hung VW, Kwok AW, Zhu TY, Kun EW, Leung PC, Li EK, Tam LS (2013) SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength. Lupus 22:1162\u20131168","journal-title":"Lupus"},{"key":"7824_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/0961203309345775","volume":"19","author":"SM Toloza","year":"2010","unstructured":"Toloza SM, Cole DE, Gladman DD, Ibanez D, Urowitz MB (2010) Vitamin D insufficiency in a large female SLE cohort. Lupus 19:13\u201319","journal-title":"Lupus"},{"key":"7824_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X19876468","volume":"11","author":"G Adami","year":"2019","unstructured":"Adami G, Rahn EJ, Saag KG (2019) Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice. Ther Adv Musculoskelet Dis 11:1759720X19876468","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"7824_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41584-024-01120-w","volume":"20","author":"F Buttgereit","year":"2024","unstructured":"Buttgereit F, Palmowski A, Bond M, Adami G, Dejaco C (2024) Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Nat Rev Rheumatol 20:417\u2013431","journal-title":"Nat Rev Rheumatol"},{"key":"7824_CR7","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/art.42646","volume":"75","author":"MB Humphrey","year":"2023","unstructured":"Humphrey MB, Russell L, Danila MI et al (2023) 2022 American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol 75:2088\u20132102","journal-title":"Arthritis Rheumatol"},{"key":"7824_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jocd.2017.06.014","volume":"20","author":"RK Jain","year":"2017","unstructured":"Jain RK, Vokes T (2017) Dual-energy X-ray absorptiometry. J Clin Densitom 20:291\u2013303","journal-title":"J Clin Densitom"},{"key":"7824_CR9","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1177\/09612033231202701","volume":"32","author":"F Ceccarelli","year":"2023","unstructured":"Ceccarelli F, Olivieri G, Orefice V, Picciariello L, Natalucci F, Conti F (2023) Fragility fractures in lupus patients: associated factors and comparison of four fracture risk assessment tools. Lupus 32:1320\u20131327","journal-title":"Lupus"},{"key":"7824_CR10","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/acr.20150","volume":"62","author":"G Schmajuk","year":"2010","unstructured":"Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J (2010) Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res (Hoboken) 62:993\u20131001","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"7824_CR11","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s00198-012-2177-5","volume":"24","author":"XL Tang","year":"2013","unstructured":"Tang XL, Qin L, Kwok AW, Zhu TY, Kun EW, Hung VW, Griffith JF, Leung PC, Li EK, Tam LS (2013) Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT. Osteoporos Int 24:1817\u20131826","journal-title":"Osteoporos Int"},{"key":"7824_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1359\/JBMR.040134","volume":"19","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893\u2013899","journal-title":"J Bone Miner Res"},{"key":"7824_CR13","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/art.11283","volume":"48","author":"TP Van Staa","year":"2003","unstructured":"Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224\u20133229","journal-title":"Arthritis Rheum"},{"key":"7824_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10067-009-1105-3","volume":"28","author":"C Mendoza-Pinto","year":"2009","unstructured":"Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H et al (2009) Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 28:579\u2013585","journal-title":"Clin Rheumatol"},{"key":"7824_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMcp1012926","volume":"365","author":"RS Weinstein","year":"2011","unstructured":"Weinstein RS (2011) Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 365:62\u201370","journal-title":"N Engl J Med"},{"key":"7824_CR16","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvae146","volume":"191","author":"J Paccou","year":"2024","unstructured":"Paccou J, Yavropoulou MP, Naciu AM et al (2024) Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society. Eur J Endocrinol 191:G1\u2013G17","journal-title":"Eur J Endocrinol"},{"key":"7824_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115297","volume":"134","author":"G Adami","year":"2020","unstructured":"Adami G, Arioli G, Bianchi G et al (2020) Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: a 5-year follow-up study. Bone 134:115297","journal-title":"Bone"},{"key":"7824_CR18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s40520-019-01294-4","volume":"31","author":"A Diez-Perez","year":"2019","unstructured":"Diez-Perez A, Brandi ML, Al-Daghri N et al (2019) Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clin Exp Res 31:1375\u20131389","journal-title":"Aging Clin Exp Res"},{"key":"7824_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40520-024-02784-w","volume":"36","author":"NR Fuggle","year":"2024","unstructured":"Fuggle NR, Reginster JY, Al-Daghri N et al (2024) Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art. Aging Clin Exp Res 36:135","journal-title":"Aging Clin Exp Res"},{"key":"7824_CR20","first-page":"1661","volume":"18","author":"VC Bojinca","year":"2019","unstructured":"Bojinca VC, Popescu CC, Decianu RD, Dobrescu A, Balanescu SM, Balanescu AR, Bojinca M (2019) A novel quantitative method for estimating bone mineral density using B-mode ultrasound and radiofrequency signals-a pilot study on patients with rheumatoid arthritis. Exp Ther Med 18:1661\u20131668","journal-title":"Exp Ther Med"},{"key":"7824_CR21","doi-asserted-by":"crossref","unstructured":"Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for C, Economic Aspects of O, Osteoarthritis, the Committee of Scientific Advisors of the International Osteoporosis F (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23-57","DOI":"10.1007\/s00198-012-2074-y"},{"key":"7824_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115786","volume":"143","author":"B Cortet","year":"2021","unstructured":"Cortet B, Dennison E, Diez-Perez A, Locquet M, Muratore M, Nogu\u00e9s X, Ovejero Crespo D, Quarta E, Brandi ML (2021) Radiofrequency echographic multi spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context. Bone 143:115786","journal-title":"Bone"},{"key":"7824_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40520-022-02286-7","volume":"35","author":"A Fassio","year":"2023","unstructured":"Fassio A, Andreola S, Gatti D, Bianco B, Gatti M, Gambaro G, Rossini M, Viapiana O, Negrelli R, Adami G (2023) Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting. Aging Clin Exp Res 35:185\u2013192","journal-title":"Aging Clin Exp Res"},{"key":"7824_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s40520-024-02728-4","volume":"36","author":"A Giovanni","year":"2024","unstructured":"Giovanni A, Luisa BM, Carla C et al (2024) Bone health status evaluation in men by means of REMS technology. Aging Clin Exp Res 36:74","journal-title":"Aging Clin Exp Res"},{"key":"7824_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11133761","author":"P Lalli","year":"2022","unstructured":"Lalli P, Mautino C, Busso C, Bardesono F, Di Monaco M, Lippi L, Invernizzi M, Minetto MA (2022) Reproducibility and accuracy of the radiofrequency echographic multi-spectrometry for femoral mineral density estimation and discriminative power of the femoral fragility score in patients with primary and disuse-related osteoporosis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11133761","journal-title":"J Clin Med"},{"key":"7824_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14182106","author":"A Fassio","year":"2024","unstructured":"Fassio A, Adami G, Andreola S et al (2024) Radiofrequency echographic multi spectrometry (REMS) technology for bone health status evaluation in kidney transplant recipients. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics14182106","journal-title":"Diagnostics (Basel)"},{"key":"7824_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40520-021-01889-w","volume":"34","author":"C Caffarelli","year":"2022","unstructured":"Caffarelli C, Tomai Pitinca MD, Al Refaie A, Ceccarelli E, Gonnelli S (2022) Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes. Aging Clin Exp Res 34:121\u2013127","journal-title":"Aging Clin Exp Res"},{"key":"7824_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejogrb.2021.06.014","volume":"263","author":"VA Degennaro","year":"2021","unstructured":"Degennaro VA, Brandi ML, Cagninelli G et al (2021) First assessment of bone mineral density in healthy pregnant women by means of radiofrequency echographic multi spectrometry (REMS) technology. Eur J Obstet Gynecol Reprod Biol 263:44\u201349","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"7824_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.5603\/EP.a2020.0056","volume":"71","author":"M Rolla","year":"2020","unstructured":"Rolla M, Halupczok-\u017by\u0142a J, Jawiarczyk-Przyby\u0142owska A, Bolanowski M (2020) Bone densitometry by radiofrequency echographic multi-spectrometry (REMS) in acromegaly patients. Endokrynol Pol 71:524\u2013531","journal-title":"Endokrynol Pol"},{"key":"7824_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12891-022-05430-6","volume":"23","author":"C Caffarelli","year":"2022","unstructured":"Caffarelli C, Tomai Pitinca MD, Al Refaie A, De Vita M, Catapano S, Gonnelli S (2022) Could radiofrequency echographic multispectrometry (REMS) overcome the overestimation in BMD by dual-energy X-ray absorptiometry (DXA) at the lumbar spine? BMC Musculoskelet Disord 23:469","journal-title":"BMC Musculoskelet Disord"},{"key":"7824_CR31","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/jbmr.3523","volume":"33","author":"A Balasubramanian","year":"2018","unstructured":"Balasubramanian A, Wade SW, Adler RA, Saag K, Pannacciulli N, Curtis JR (2018) Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions. J Bone Miner Res 33:1881\u20131888","journal-title":"J Bone Miner Res"},{"key":"7824_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/acr.20568","volume":"64","author":"IE Bultink","year":"2012","unstructured":"Bultink IE (2012) Osteoporosis and fractures in systemic lupus erythematosus. Arthritis Care Res Hoboken 64:2\u20138","journal-title":"Arthritis Care Res Hoboken"},{"key":"7824_CR33","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3899\/jrheum.081337","volume":"36","author":"EK Li","year":"2009","unstructured":"Li EK, Tam LS, Griffith JF et al (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36:1646\u20131652","journal-title":"J Rheumatol"},{"key":"7824_CR34","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s00198-025-07685-w","volume":"36","author":"M Bobelyak","year":"2025","unstructured":"Bobelyak M, Vaculik J, Stepan JJ (2025) Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement. Osteoporos Int 36:2237\u20132244","journal-title":"Osteoporos Int"},{"key":"7824_CR35","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.ultrasmedbio.2016.01.024","volume":"42","author":"S Casciaro","year":"2016","unstructured":"Casciaro S, Peccarisi M, Pisani P et al (2016) An advanced quantitative echosound methodology for femoral neck densitometry. Ultrasound Med Biol 42:1337\u20131356","journal-title":"Ultrasound Med Biol"},{"key":"7824_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ultrasmedbio.2014.08.017","volume":"41","author":"F Conversano","year":"2015","unstructured":"Conversano F, Franchini R, Greco A et al (2015) A novel ultrasound methodology for estimating spine mineral density. Ultrasound Med Biol 41:281\u2013300","journal-title":"Ultrasound Med Biol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07824-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-025-07824-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-025-07824-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:09:17Z","timestamp":1772582957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-025-07824-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7824"],"URL":"https:\/\/doi.org\/10.1007\/s00198-025-07824-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the protocol REUMABANK approved by our local Ethics Committee, in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was collected for each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Patients provided consent for publication of anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Giovanni Adami has received advisory board honoraria, consultancy fees and\/or speaker fees from Theramex, UCB, Lilly, Galapagos, Fresenius Kabi, Amgen, BMS, Abiogen and Pfizer. Davide Gatti has received advisory board honoraria, consultancy fees and\/or speaker fees from Accord Health Care, Abiogen, Amgen, Eli-Lilly, Mereo, Neopharmed-Gentili, UCB. Maurizio Rossini reports advisory board honoraria, consultancy fees and\/or speaker fees from AbbVie, ItalFrarmaco, Neopharmed-Gentili, Eli-Lilly, Theramex, UCB, outside the submitted work. Ombretta Viapiana has received advisory board honoraria and speaker fees from Gilead, Fresenius Kabi, Biogen, Eli-Lilly, UCB, Abbvie, MSD, BMS. Angelo Fassio reports personal fees from Abiogen, Novartis, Neopharmed. The other authors have disclosed no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}